The significantly lower mRNA expression levels of RANKL and OPG genes in patients with primary SLE may be related to the abnormal expression of RANKLx and OPG genes due to the abnormal function of T and B cells, which in turn caused the reduction of bone mass in SLE patients (52). This evidence concerns the gene TNFSF11 and systemic lupus erythematosus.